Bigul

Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

This is to inform you that the Committee of Directors (Allotment) of the Board of Directors of the Company at its meeting held today, has allotted 6696 (Six thousand six hundred ninety six) equity shares of Re. 1/- each, on exercise of stock options under the SUN Employee Stock Option Scheme- 2015. Accordingly, post the above allotment of equity shares, the paid-up equity share capital of the Company is Rs. 2,39,93,34,970/- (Rupees Two Hundred and Thirty Nine Crore Ninety Three Lakhs Thirty Four Thousand Nine Hundred and Seventy Only) divided into 2,39,93,34,970 (Two Hundred and Thirty Nine Crore Ninety Three Lakhs Thirty Four Thousand Nine Hundred and Seventy) equity shares of Re.l/- each. Kindly take the same on record.
11-02-2019
Bigul

Sun Pharma surges 5% as US arm Taro posts healthy December quarter results

The stock was up 5 per cent at Rs 436 on the BSE in intra-day trade after its US subsidiary Taro Pharmaceutical reported strong results for the quarter ended December 2018.
07-02-2019
Bigul

Sun Pharmaceutical Industries Ltd - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shangvi Finance Pvt Ltd
06-02-2019
Bigul

Sun Pharmaceutical Industries Ltd - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shanghvi Finance Pvt Ltd
02-02-2019
Bigul

Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

We are pleased to enclose herewith our Press Release relating to announcement of financial results for the third quarter and nine month ending December 31, 2018, which we shall be releasing after sending this letter to you. This is for your information and record. Thanking you,
28-01-2019
Bigul

Sun Pharmaceutical Industries Ltd - 524715 - Board Meeting Intimation for Notice Of Board Meeting For Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2018 And Intimation Of Dates Of Window Closure For Trading By Designated Persons.

SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2019 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday, February 12, 2019, to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31,2018. In view of the above, the window closure for trading by designated persons as per Insider Trading Rules of the Company will be from Friday, February 01,2019 to Thursday, February 14, 2019 (both days inclusive). This is for your information and record.
25-01-2019
Bigul

Sun Pharmaceutical Industries Ltd - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Raksha Sudhir Valia
24-01-2019
Bigul

Sun Pharma: Too little, too late?

In total, Rs 10,665 crore of investor wealth has been lost between the two investor updates.
23-01-2019
Bigul

Sun Pharma to settle Dubai firm loans, shift distribution arm to subsidiary

Sun Pharma in damage control mode after stock loses about 30% of its value since Sept due to corporate governance concerns
23-01-2019
Bigul

Sun Pharma's damage-control exercise does not quell the many concerns

But some analysts question why this disclosure was being made only after much prodding.
22-01-2019
Next Page
Close

Let's Open Free Demat Account